On December 19, 2023,Genetic Engineering & Biotechnology News reported on the expanded funding of the Hevolution-AFAR New Investigator Awards in Aging Biology and Geroscience Research through a $16 million award from Hevolution Foundation.
AFAR and the Hevolution Foundation launched the new investigator awards in 2022. In its first cycle, the program funded 18 research projects, spanning topics such as cellular senescence, compounds such as metformin and rapamycin, and translational topics such as data-guided drug discovery.
The new funding will provide support in 2023 and 2024 for up to 36 investigators in Canada and the U.S. with three-year awards of $375,000 each.
AFAR anticipates announcing the 2023 New Investigators in early 2024.
Read the article, “Hevolution Foundation Grant Expands New Investigator Awards in Geroscience”, here.
Learn more about this AFAR grant program here. Explore to the perspectives of many of the inaugural New Investigators in AFAR’s Grantee Spotlight Interviews here.
